Nova Patents
IL293220B2

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

51 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
31125510United States of AmericaP
201161435671United States of AmericaP
2011027317United States of AmericaW

Members51

Family members, oldest first
DocumentOfficeKind
CA2791383A1CanadaA1
CA3083324A1CanadaA1
WO2011109789A2World Intellectual Property Organization (WIPO)A2
WO2011109789A3World Intellectual Property Organization (WIPO)A3
EP2542590A2European Patent Office (EPO)A2
US2013039911A1United States of AmericaA1
JP2013521311AJapanA
EP2542590A4European Patent Office (EPO)A4
US8993524B2United States of AmericaB2
US2015183881A1United States of AmericaA1
US9441044B2United States of AmericaB2
US2016340430A1United States of AmericaA1
JP6066732B2JapanB2
JP2017043600AJapanA
EP2542590B1European Patent Office (EPO)B1
US2017158770A1United States of AmericaA1
DK2542590T3DenmarkT3
PT2542590TPortugalT
ES2638521T3SpainT3
PL2542590T3PolandT3
US9850306B2United States of AmericaB2
EP3260470A1European Patent Office (EPO)A1
JP6378262B2JapanB2
JP2018172439AJapanA
IL266971D0IsraelD0
US10442860B2United States of AmericaB2
EP2542590B2European Patent Office (EPO)B2
US2020115455A1United States of AmericaA1
IL221607AIsraelA
IL221607BIsraelB
DK2542590T4DenmarkT4
PL2542590T5PolandT5
ES2638521T5SpainT5
EP3798237A1European Patent Office (EPO)A1
JP2021143189AJapanA
US11274156B2United States of AmericaB2
IL266971AIsraelA
IL266971BIsraelB
US2022204628A1United States of AmericaA1
IL293220AIsraelA
CA2791383CCanadaC
JP7212468B2JapanB2
IL293220B1IsraelB1
IL300733AIsraelA
IL293220B2This recordIsraelB2
US2025009772A1United States of AmericaA1
US12295968B2United States of AmericaB2
IL300733B1IsraelB1
IL323000AIsraelA
CA3253628A1CanadaA1
IL300733B2IsraelB2